Detection of chromosome aberrations in interphase tumor nuclei by nonradioactive in situ hybridization.
In a blind study, chromosome aberrations in tumor cells were analyzed by conventional cytogenetic techniques (G banding) and nonradioactive in situ hybridization with chromosome-specific probes. The material was obtained directly from patients with hematologic diseases and from colon tumor derived cell lines. The cytogenetic data obtained with G banding were in accord with those obtained by in situ hybridization to metaphase chromosomes. Most importantly, in situ hybridization to interphase nuclei gave reliable results and even allowed detection of cell subpopulations that were not detected by analyzing metaphase chromosomes. Furthermore, in retrospect, even structural aberrations could be detected in interphase nuclei; abnormal cells with either an i(1q) or a translocation der(1)t(1;7) could be identified. Our results show that the application of in situ hybridization in combination with routine cytogenetic techniques offers significant advantages for cytogenetic analysis of solid tumors and hematologic malignancies.
Nederlof
P M
PM
Department of Cytochemistry and Cytometry, University of Leiden, The Netherlands.
van der Flier
S
S
Raap
A K
AK
Tanke
H J
HJ
van der Ploeg
M
M
Kornips
F
F
Geraedts
J P
JP
D002288:Adenocarcinoma, Mucinous / Q000235:genetics*; D000368:Aged; D000369:Aged, 80 and over; D001853:Bone Marrow / Q000648:ultrastructure; D002467:Cell Nucleus / Q000648:ultrastructure; D002869:Chromosome Aberrations; D003110:Colonic Neoplasms / Q000235:genetics*; D015342:DNA Probes; D005260:Female; D006402:Hematologic Diseases / Q000235:genetics*; D006801:Humans; D007399:Interphase; D008297:Male; D008875:Middle Aged; D009693:Nucleic Acid Hybridization; D014407:Tumor Cells, Cultured
D015342:DNA Probes